1-20 of 3228
melphalan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

Clinical Trials & Observations
Lauri M. Burroughs, Aleksandra Petrovic, Ruta Brazauskas, Xuerong Liu, Linda M. Griffith, Hans D. Ochs, Jack J. Bleesing, Stephanie Edwards, Christopher C. Dvorak, Sonali Chaudhury, Susan E. Prockop, Ralph Quinones, Frederick D. Goldman, Troy C. Quigg, Shanmuganathan Chandrakasan, Angela R. Smith, Suhag Parikh, Blachy J. Dávila Saldaña, Monica S. Thakar, Rachel Phelan, Shalini Shenoy, Lisa R. Forbes, Caridad Martinez, Deepak Chellapandian, Evan Shereck, Holly K. Miller, Neena Kapoor, Jessie L. Barnum, Hey Chong, David C. Shyr, Karin Chen, Rolla Abu-Arja, Ami J. Shah, Katja G. Weinacht, Theodore B. Moore, Avni Joshi, Kenneth B. DeSantes, Alfred P. Gillio, Geoffrey D. E. Cuvelier, Michael D. Keller, Jacob Rozmus, Troy Torgerson, Michael A. Pulsipher, Elie Haddad, Kathleen E. Sullivan, Brent R. Logan, Donald B. Kohn, Jennifer M. Puck, Luigi D. Notarangelo, Sung-Yun Pai, David J. Rawlings, Morton J. Cowan
Journal: Blood
Blood (2020) 135 (23): 2094–2105.
https://doi.org/10.1182/blood.2019002939
Published: 2020
Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Brief Report
Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin
Journal: Blood
Blood (2020) 135 (6): 449–452.
https://doi.org/10.1182/blood.2019003662
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical Characteristics, Treatment Regimens and Survival in Elderly Patients with AL Amyloidosis in a Tertiary Referral Center

Jose Acevedo, Gheorghe Doros, PhD, Raphael Szalat, John Mark Sloan, MD, Shayna Sarosiek, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5447.
https://doi.org/10.1182/blood-2019-124980
Published: 2019
Journal Articles

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Akira Honda, MD PhD, Yu Oyama, MD, Kazuhiro Toyama, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5492.
https://doi.org/10.1182/blood-2019-129324
Published: 2019
Journal Articles

Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review

Maimoona Khan, MBBS, Asma Waheed, MBBS, Rida Ul Jannat, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhaddis Ejaz Ahmad, MD, Muhammad Abdullah Yousaf, MBBS, MD, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Sravanthi Kotapati, MBBS, Irbaz Riaz, MDMMSc, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5588.
https://doi.org/10.1182/blood-2019-128833
Published: 2019
Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5657.
https://doi.org/10.1182/blood-2019-122467
Published: 2019
Journal Articles

A Phase I Trial of Venetoclax in Combination with BEAM Conditioning Chemotherapy (V-BEAM) with Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma

Allison M. Winter, MD, Kirsten M Boughan, DO, Jack Khouri, MD, Paolo Caimi, MD, Faiz Anwer, MD, Brenda Cooper, MD, Deepa Jagadeesh, MDMPH, Robert M. Dean, MD, Aaron T. Gerds, MD MS, Ronald Sobecks, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Marcos de Lima, MD, Navneet S. Majhail, MD MS, Brian T. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5705.
https://doi.org/10.1182/blood-2019-124602
Published: 2019
Journal Articles

Subcutaneous Bortezomib, Thalidomide and Dexamethasone As Induction Therapy Prior to Autologous Peripheral Blood Stem Cell Transplantation in Young Patients Diagnosed of Multiple Myeloma. a Retrospective Analysis from Two Centers

David Jiménez Ruiz De La Torre, MD, Gladys Ibarra, MD, Maite Encuentra, Laura Abril, MD, Albert Oriol, MD, Josep-Maria Ribera, MD PhD, Anna Sureda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5568.
https://doi.org/10.1182/blood-2019-130107
Published: 2019
Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Kaiyang Ding, Bingzong Li, MD PhD, Bing Chen, Zhengzheng Fu, Sili Wang, Wenhao Zhang, MD PhD, Xin Zhou, Luoming Hua, PhD, Wei Yang, Luo Jun, Liang Wang, Tianhong Xu, Yang Yang, Weida Wang, MD, Guolin Wu, Yun Huang, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5592.
https://doi.org/10.1182/blood-2019-130040
Published: 2019
Journal Articles

Evolving Data on CAR T-Cell Therapy for Multiple Myeloma, Novel Targets, Conditioning Regimens and Novel Constructs: A Systematic Review

Yusra Shao, MD, Daniel S Carlson, DO, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5547.
https://doi.org/10.1182/blood-2019-122292
Published: 2019
Journal Articles

Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation

Akira Tanimura, Koji Okazaki, MD, Yuko Okuda, MD, Risen Hirai, MD, Daisuke Kudo, MD, Masataka Takeshita, MD PhD, Akiyoshi Miwa, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5706.
https://doi.org/10.1182/blood-2019-122084
Published: 2019
Journal Articles

Eltrombopag Following Chemotherapy and G-CSF+/- Plerixafor for Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Lymphoma and Myeloma Patients

Krishna Joshi, MD, Appalanaidu Sasapu, MD, Muthu Veeraputhiran, MD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Michele H Cottler-Fox, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5638.
https://doi.org/10.1182/blood-2019-124629
Published: 2019
Journal Articles

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Abdul Aziz Siddiqui, MD, Kazi Najamus-saqib Khan, Arafat Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Muhammad Junaid Tariq, MD, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5574.
https://doi.org/10.1182/blood-2019-132095
Published: 2019
Journal Articles

Outcomes of Autologous Hematopoietic Stem Cell Transplantation Depending on Body-Mass Index in Patients with Multiple Myeloma

Maiia V. Firsova, Larisa P. Mendeleeva, MD PhD Prof, Maxim V. Solovev, MD PhD, Valery G. Savchenko, MD PhD academician
Journal: Blood
Blood (2019) 134 (Supplement_1): 5710.
https://doi.org/10.1182/blood-2019-125808
Published: 2019
Journal Articles

Incidence and Outcomes of Extramedullary Myeloma in a South Australian Hospital

Angelina Yong, BSc,BMBS, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5504.
https://doi.org/10.1182/blood-2019-129754
Published: 2019
Journal Articles

A Real-Life Study of Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma Older Than 65 Years in a Latin American Country

Cristian Maximiliano Seehaus, MD, Natalia Paola Schutz, MDMSc, Erika Barbara Brulc, MD, Leandro Burgos Pratx, MD, Gonzalo Ariel Ferini, MD, Jorge A Arbelbide, MD, Dorotea Fantl, MD, Ana Lisa Basquiera, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5711.
https://doi.org/10.1182/blood-2019-130171
Published: 2019
Journal Articles

Clinically Suspected Cast Nephropathy: A Retrospective, Multi-Center, Real-World Study

Agoston Gyula Szabo, MD, Jonathan Thorsen, MD PhD, Charlotte Toftmann Hansen, MD PhD, Maja Ølholm Vase, MD PhD, Manuela Teodorescu, MD, Simon Bo Pedersen, MD, Simon Bertram Flæng, MD, Ulf Christian Frølund, MD, Annette Juul Vangsted, MD PhD, Torben Plesner, MD DSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5553.
https://doi.org/10.1182/blood-2019-124336
Published: 2019
Journal Articles

Viability of Stem Cells without Cryopreservation: How Good and How Long?

Mie Mie Khine, Hnin Mya Thandar, MD, Aye Aye Gyi, MBBS, MMSc, MRCP, DM, FRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 5637.
https://doi.org/10.1182/blood-2019-132261
Published: 2019
Journal Articles

Profile of Long-Term Survivors in Multiple Myeloma

Florence Sabirou, Gautier Defossez, MD, Pierre Ingrand, PhD, Isabelle Azais, MD, Geraldine Durand, MD, Niels Moya, Cécile Gruchet, Anthony Levy, Arthur Bobin, Helene Gardeney, Laly Nsiala, Carine Motard, MD, Gaelle Olivier, MD, Anne Corby, MD, Christophe Roul, MD, Thomas Systchenko, MD, Jocelyn Barrier, MD, Celine Dieval, MD, Florence Borde, MD, Olivier Fitoussi, MD, Antoine Machet, MD, Pierre Jamet, MD, Jeremie Diolez, MD, Stephanie Guidez, MD, Xavier Leleu, MD PhD, Mathieu Puyade, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5522.
https://doi.org/10.1182/blood-2019-127519
Published: 2019
Journal Articles

Comparison of Early Versus Delayed Filgrastim (G-CSF) Administration Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma - Real-World Data from a Single-Center Institution

Jorge Monge, MD, Kari Flicker, BS, Danielle Guarneri, BS, CCRP, Robin S. Solomon, Jin Guo, MD, Jorge Contreras, MD, Natalie Agudo, RN, David S Jayabalan, MSc, Kathleen Pogonowski, RN, Brielle Liotta, BS, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Sebastian A. Mayer, MD, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Morton Coleman, MD, Cara A. Rosenbaum, MD, Roger Pearse, MD PhD, Adriana C. Rossi, MDMSc, Ruben Niesvizky, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5644.
https://doi.org/10.1182/blood-2019-130914
Published: 2019